(Q47901082)

6 February 2018

title

A vaccine against malaria: a substantial step forward (English)

1 reference

6 February 2018

0 references

1 reference

2

1 reference

6 February 2018

Marie Paule Kieny

series ordinal

3

object named as

Marie-Paule Kieny

1 reference

6 February 2018

author name string

Vasee Moorthy

series ordinal

1

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 April 2009

1 reference

6 February 2018

published in

The Lancet

1 reference

6 February 2018

volume

373

1 reference

6 February 2018

issue

9673

1 reference

6 February 2018

page(s)

1411-1412

1 reference

6 February 2018

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960802-3

7 January 2021

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960802-3

7 January 2021

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960802-3

7 January 2021

Malaria vaccine: 3 or 6 months' protection?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960802-3

7 January 2021

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960802-3

7 January 2021

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960802-3

7 January 2021

What will a partly protective malaria vaccine mean to mothers in Africa?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960802-3

7 January 2021

MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials--scientific, regulatory and public health perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960802-3

7 January 2021

Measurement of malaria vaccine efficacy in phase III trials: report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960802-3

7 January 2021

10.1016/S0140-6736(09)60802-3

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018